Topics

Global offering raises $557M for cancer treatment developer Argenx

05:57 EST 13 Nov 2019 | SmartBrief

Argenx, a biotech firm developing treatments for immune thrombocytopenia and myasthenia gravis, raised $557 million from a gl -More

Original Article: Global offering raises $557M for cancer treatment developer Argenx

NEXT ARTICLE

More From BioPortfolio on "Global offering raises $557M for cancer treatment developer Argenx"

Quick Search

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...